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Edited by Lukas HuberAbstract In response to osmotic cell swelling, Intestine 407 cells
react with a rapid and transient activation of phospholipase D
(PLD). To investigate the role of PLD during the regulatory
volume decrease, cells were treated with 1-butanol resulting in a
depletion of PLD substrates. Activation of volume-regulated anion
channels, but not the cell swelling-induced release of taurine, was
largely inhibited in the presence of low concentrations of 1-butanol.
In addition, hypotonicity-induced exocytosis, ATP release and
subsequent endocytosis were found to be largely abrogated. The
results support a model of cell volume regulation in which PLD
plays an essential role in the cell swelling-induced vesicle cycling
and in the activation of volume-sensitive anion channels.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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As a consequence of the relatively high water permeability of
the plasma membrane, an osmotic imbalance between cells and
their surrounding ﬂuids will immediately lead to a change in
cellular volume. Because volume alterations are potentially
deleterious, almost all mammalian cell types have developed
compensatory mechanisms that keep the cell volume within a
narrow range. Upon osmotic cell swelling, Cl- and Kþ-se-
lective ion channels are rapidly activated, leading to a net ef-
ﬂux of KCl followed by water (regulatory volume decrease,
RVD). In addition, a release of organic osmolytes (taurine and
b-alanine) has been demonstrated in a variety of diﬀerent cell
types (for review see [1]).
Previously, we reported that in Intestine 407 epithelial cells,
the activation of volume-regulated anion channels (VRACs)
depends on protein tyrosine phosphorylation and on the ac-
tivity of the p21Rho G-protein [2,3]. In addition, we demon-
strated that osmotic cell swelling promotes a robust increase in
vesicle cycling, responsible for the concomitant release of ATP
[4,5]. Because RhoA and ARF type GTPases have been im-
plicated in the regulation of phospholipase D (PLD) [6–8] and
a potential role of PLD in membrane traﬃc has been emerged
from previous studies [9,10], we hypothesized that this enzyme
may act as a key regulator of the RVD response.* Corresponding author. Fax: +31-10-4089472.
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doi:10.1016/j.febslet.2004.04.063In a variety of cell models, activation of PLD has been ob-
served upon stimulation with growth factors, hormones as well
as cytokines (for review see: [6,7,11]). In addition, activation of
PLD by hypo-osmolarity has been demonstrated in the pro-
tozoan Leishmania donovani and in skate erythrocytes [12,13].
To date, only two PLD genes have been cloned from mam-
malian cells, PLD1 and PLD2, each being expressed as two
splice variants [14,15]. Whereas PLD1 appears to be localized
primarily on intracellular membranes [16,17], including the
Golgi apparatus, PLD2 seems to be conﬁned mainly to the
plasma membrane [8,16,17]. Like many other esterases, PLD
can utilize short chain primary alcohols (like ethanol and 1-
butanol) as phosphatidyl group acceptors, resulting in the
formation of metabolically stable phosphatidyl alcohols
[6,11,18–20]. This property can be used not only to detect PLD
activation, but, due to depletion of cellular PtdOH levels, can
also serve as a tool to evaluate the physiological role of PLD [6].
In this study, we have used 1-butanol-treated cultures of
Intestine 407 epithelial cells as a model to investigate the role
of PLD during the RVD response. The results indicate that the
compensatory eﬄux of organic osmolytes is rather insensitive
to 1-butanol treatment. In contrast however, the hypotonicity-
provoked cycling of membrane vesicles as well as the activa-
tion of volume-sensitive anion channels were largely inhibited.2. Materials and methods
2.1. Materials
Radioisotopes (125I, [32P]orthophosphate and [3H]taurine) were
purchased from Amersham Netherlands B.V. (‘s Hertogenbosch, The
Netherlands). FM 1–43 was obtained from Molecular Probes (Eugene,
OR). All other reagents were from Sigma–Aldrich (St. Louis, MO).
2.2. Cell culture
Intestine 407 cells were grown as monolayers in Dulbecco’s modiﬁed
Eagle’s medium supplemented with 25 mM HEPES, 10% FCS, 1%
non-essential amino acids, 40 mg/l penicillin and 90 mg/l streptomycin
under a humidiﬁed atmosphere of 95% O2 and 5% CO2 at 37 C. Prior
to the experiments, the cells were serum-starved overnight.
2.3. Eﬄux assay
Monolayers of Intestinal 407 cells were loaded for 2 h with 5 lCi 125I
and washed three times with isotonic buﬀer (80 mM NaCl, 5 mM KCl,
1.3 mM CaCl2, 1 mMMgCl2, 10 mM glucose, 95 mMmannitol and 20
mM HEPES, pH 7.4) prior to the assay. Isotope eﬄux was determined
at 37 C by replacing the medium at 1–2-min intervals. Hypotonic
buﬀers were prepared by reducing the concentration of mannitol. Ra-
dioactivity in the media was determined by c-radiation counting and
expressed as fractional eﬄux per minute as previously described [2].
2.4. Phospholipase D activity
Cells were labelled overnight with p32P]orthophosphate (100 lCi/
ml). 1-Butanol was added 15 min before the start of the experiments.ation of European Biochemical Societies.
Fig. 1. Activation of PLD by osmotic cell swelling. Intestine 407 cells
were labelled with 32PO34 and PLD activity was subsequently deter-
mined by quantitating the amount of [32P]PtdBut formed. (A) Autora-
diogram of 32P-labelled phospholipids in control and hypo-osmotically
(70% tonicity) stimulated cells. Phospholipids were separated by
HPTLC, and the positions of the PtdBut and PtdOH were indicated by
arrows. (B) Time dependency of the PtdBut formation in control (open
symbols) and hypotonicity-treated cells (closed symbols). (C) Accu-
mulation of inositol phosphates in control (Con), hypo-osmotically
(Hypo) and bradykinin (1 lM, 10 min, BK) stimulated [3H]inositol-
loaded (2 lM, 18 h) cultures. Inositol phosphates were quantitated by
Dowex AG 1 X 8 anion-exchange chromatography as described [32].
(D) Inhibition of the osmotic cell swelling-induced PtdBut formation in
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M HCl. Culture plates were then stored at )20 C for 30 min. Lipids
were isolated by a modiﬁed acid Bligh and Dyer extraction [21].
Brieﬂy, after thawing, cells were scraped and transferred to 2 ml vials
and centrifuged at 10 000 g for 60 s. Supernatants were discarded and
the pellets were resuspended in 1 ml CHCl3:MeOH:HCl (50:100:1 v/v).
Phase separation was achieved by adding 750 ll chloroform and 300 ll
of 2 N HCl. The lower phase was collected, washed twice with
CHCl3:MeOH:1 M HCl (3:48:47 v/v), dried and dissolved in chloro-
form. Phospholipids were separated on Silica-60 HPTLC plates
(Merck Darmstadt, Germany) using the upper phase of an ethyl-ace-
tate:iso-octane:formic-acid:H2O (130:20:30:100 v/v) solvent system
[21].
2.5. Exocytosis
FM 1–43 loading experiments were performed with cells grown on
coverslips, at approx. 50% conﬂuency. During exposure to 1 lM FM
1–43, changes in ﬂuorescence intensity were measured online (excita-
tion wavelength¼ 479 nm; emission wavelength¼ 598 nm) in a ﬂuo-
rescence spectrophotometer (Hitachi F4500, Tiel, Holland) at 37 C, as
described previously [5].
2.6. ATP release
Cultures of Intestine 407 cells were washed four times with isotonic
buﬀer prior to osmotic stimulation. Thereafter, media were collected,
centrifuged for 5 min at 300 g and the supernatants were transferred
to fresh vials. ATP content was determined using a luciferin–luciferase
luminescence kit (Promega Corporation, Medison, WI) and a Top-
count. NXT luminometer (Packard, Meriden, CT) as described [4].
2.7. TRITC-dextran uptake
Cells grown on coverslips (90% conﬂuent) were incubated with 0.5
mg/ml TRITC-dextran (MW¼ 10 000 Da) in iso- or hypotonic buﬀer.
After incubation, cells were washed three times with ice-cold phos-
phate-buﬀered saline (PBS) and ﬁxed with in 2% formaldehyde in PBS
(20 min incubation). Confocal images of 512 512 pixels were con-
structed by summation of 15 optical sections parallel to the substratum
and each 1 lm apart, using a 63 oil immersion objective (Axiovert
135 M, Zeiss, Oberkochen, Germany). Endocytosis was quantiﬁed
using KS400 software (Zeiss, Oberkochen, Germany) [5].genistein (200 lM, 30min) andGF109203X (1 lM, 15min) treated cells.
Data are expressed as percentage relative to the isotonic control
(meansS.E.M. for n ¼ 3).3. Results and discussion
3.1. Osmotic cell swelling-provoked activation of PLD
Using 1-butanol-treated cultures of Intestine 407 cells, we
studied the activation of PLD during the RVD response. As
shown in Fig. 1A and B, reducing the osmolarity of the me-
dium from isotonic to 70% tonicity rapidly activates PLD, as
evidenced by the accumulation of PtdBut. A steep increase in
PtdBut was observed during the ﬁrst 2 min of hypo-osmotic
stimulation, thereafter the amount slowly declined, reaching
control levels after 10–15 min (Fig. 1B). Although PtdBut is
generally believed to be relatively stable [20], a considerable
degradation of PtdBut was apparent in this intestinal epithelial
cell line, possibly leading to an underestimation of the extent of
the PLD activation during the ﬁrst 5–10 min of the RVD re-
sponse. Notably, osmotic swelling of Intestine 407 cells did not
activate phospholipase C, as determined by quantitating ino-
sitol phosphate formation (Fig. 1C).
Protein tyrosine phosphorylation plays an important role
during the RVD response. In Intestine 407 cells, as well as in a
number of other cell models [22–24], tyrosine kinase inhibition
resulted in a reduced volume-sensitive anion eﬄux [2] and a
diminished rate of vesicle cycling [5]. In contrast however, in
Intestine 407 cells, the cell swelling-induced release of organic
osmolytes like taurine and betaine was not aﬀected by tyrosine
kinase inhibition [Tomassen et al., Am. J. Physiol., in press].
To investigate the role of tyrosine kinases in the activation ofthe hypotonicity-induced PLD activation, cells were treated
with genistein, a broad speciﬁcity tyrosine kinase inhibitor. As
shown in Fig. 1D, genistein treatment completely prevented
the cell swelling-induced activation of PLD, indicating the
involvement of (a) tyrosine kinase(s) in the mechanism of os-
motic activation of the enzyme. In addition, the cell swelling-
induced activation of PLD was inhibited after treatment of the
cells with the broad range protein kinase C inhibitor
GF109203X, indicating that active protein kinase C is required
for its activation (Fig. 1D).
3.2. Possible role of PLD in the activation of compensatory
osmolyte ﬂuxes
To investigate a putative role for PLD in the regulation of
the cell swelling-induced anion and taurine release, 1-butanol-
treated cells are used to prevent the activation of PLD. Low
concentrations of 1-butanol (1%) largely reduced the cell
swelling-provoked 125I eﬄux from isotope-loaded cells but
did not appreciably aﬀect the release of [3H]taurine (Fig. 2).
The insensitivity of the [3H]taurine release to 1-butanol was
observed at all tonicities tested (30–50% hypotonicity, results
not shown). Notably, comparable concentrations of 2-butanol
(Fig. 2) or tert-butanol (not shown) were not able to diminish
the release of osmolytes. Because in most cell models studied,
1% 1-butanol or less resulted in a complete inhibition of PLD
and its downstream targets [25,26], the insensitivity of the
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Fig. 2. (A) 125Iodide (open bars) and [3H]taurine (closed bars) release
from osmotically stimulated (70% tonicity) control, 1-butanol- (1%, 60
min) and 2-butanol-treated (2%, 60 min) Intestine 407 cells. (B) Time
course of the hypotonicity-induced (70% tonicity) 125Iodide eﬄux in
the control (open symbols) and 1-butanol-treated (1%, 60 min, closed
symbols) cultures. Arrow marks the shift to a hypotonic medium. Data
are expressed as meanS.E.M. for n ¼ 3. Asterisk indicates a signif-
icant diﬀerence from the control (P < 0:01 Student’s t-test).
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Fig. 3. 1-Butanol (1%, 30 min) treated cultures of Intestine 407 cells.
(A) Time course of the hypotonic shock-induced increase in FM 1–43
ﬂuorescence. Arrow indicates a shift to a hypo-osmotic medium (70%
tonicity). Traces are representative of at least three experiments. (B,C)
Uptake of TRITC-dextran (B) and the release of ATP (C) under iso-
tonic (open bars) and hypotonic (70% tonicity, hatched bars) condi-
tions. Data are expressed as mean S.E.M. for n ¼ 3. Asterisk
indicates a signiﬁcant diﬀerence from the control (P < 0:01, Student’s
t-test).
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Fig. 4. [3H]Taurine release from osmotically (70% tonicity)-provoked
control, PMA (200 nM, 30 min), GF109203X (1 lM, 30 min) and 1-
butanol-treated (1%, 30 min) Intestine 407 cells. Data are expressed as
meanS.E.M. for n ¼ 3. Asterisk indicates a signiﬁcant diﬀerence
from the control (P < 0:01, Student’s t-test).
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likely to be involved in its activation pathway.
3.3. Involvement of PLD in the cell swelling-induced vesicle
cycling
Osmotic cell swelling is accompanied by exo- and endocy-
tosis as well as by the release of ATP [5,27]. Because PLD
activation was found to be an essential step in the mechanism
of exocytosis in several cell models [27], the role of this lipase in
the hypotonicity-provoked vesicle cycling was studied. Both
the osmotic cell swelling-induced increase in total cell surface
area, as determined by FM 1–43 ﬂuorescence, as well as the
release of ATP were completely abolished in 1-butanol (1%)
treated cells (Fig. 3A and B). In addition, a considerable re-
duction in the uptake of TRITC-dextran was observed
(Fig. 3C). Taken together, these results strongly suggest that
PLD activation is critically involved in the activation of cell
swelling-induced vesicle cycling and in the release of ATP.
3.4. Phorbolester induced potentiation of the taurine eﬄux
involves PLD
Previously we have shown that, unlike the activation of
VRAC [28], the volume-sensitive eﬄux of taurine is potenti-
ated in the presence of the phorbolester PMA [Tomassen et al.,
Am. J. Physiol., in press]. Because it is now well established
that PMA may act as a strong activator of PLD either directly
or through stimulation of PKC [11,29,30], its role in the reg-ulation of taurine eﬄux was further explored. As shown in
Fig. 4, low concentrations of 1-butanol (1%) did not aﬀect the
hypotonicity-induced taurine eﬄux under control conditions
(cf. see also Fig. 2B). Potentiation of the response by PMA,
however, was completely abolished in 1-butanol- as well as in
GF109203X-treated cultures, suggesting that the potentiation
of the taurine eﬄux by PMA involves protein kinase C acti-
vation of PLD.4. Conclusions
Hypo-osmotic cell swelling leads to the activation of PLD
through a mechanism involving tyrosine kinase(s). Unlike the
hypotonicity-provoked taurine eﬄux, the cell swelling-triggered
290 S.F.B. Tomassen et al. / FEBS Letters 566 (2004) 287–290increase in anion conductance, exo- and endocytosis as well as
the release of ATP were sensitive to low concentrations of 1-
butanol. Because 1-butanol induced depletion of PtdOH levels
is considered as a highly speciﬁc tool to inhibit PLD activity in
intact cells, the results suggest that PLD plays an important role
in both the activation of osmotic cell swelling-induced activation
of compensatory Cl channels as well as in the release of the
auto- or paracrinic factor ATP. Surprisingly, potentiation of the
taurine release by PMA was equally sensitive to 1-butanol
treatment. It is therefore tempting to suggest that PMA poten-
tiation of the taurine eﬄux involves the recruitment of an ad-
ditional pool of organic osmolytes transporters to the plasma
membrane through a mechanism that includes PLD activation.
This phenomenon may account for the observation in many cell
types that Ca2þ-mobilizing hormones and growth factors cou-
pled to protein kinase C increase the release of organic osmo-
lytes from osmotically challenged cells [31].References
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